Stephanie A Meyers-Pantele1,2, Sonia Jain3, Xiaoying Sun3, Charles Marks2,4, Kora DeBeck5, Kanna Hayashi5, Steffanie A Strathdee2, Dan Werb2,6. 1. Department of Psychology, San Diego State University, San Diego, USA. 2. Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, USA. 3. Department of Family Medicine and Public Health, University of California San Diego, La Jolla, USA. 4. School of Public Health, University of Nevada, Reno, USA. 5. British Columbia Centre on Substance Use, Vancouver, Canada. 6. Centre on Drug Policy Evaluation, St. Michael's Hospital, Toronto, Canada.
Abstract
INTRODUCTION: Injection drug use initiation is commonly facilitated by other people who inject drugs (PWID). We investigated how the gender of PWID influences their risk of providing initiation assistance to others across two distinct geo-cultural settings. METHODS: Data were drawn from two prospective cohorts in Tijuana, Mexico and Vancouver, Canada which conducted semi-annual interviews within the PReventing Injecting by Modifying Existing Responses (PRIMER) study. Participants consisted of PWID who had reported never providing injection initiation assistance at baseline. We then conducted site-specific discrete-time survival analyses assessing the relationship between gender and other relevant covariates (e.g. age and past 6-month sex work) on the risk of the first reported instance of providing initiation assistance. RESULTS: Of 1988 PWID (Tijuana: n = 596; Vancouver: n = 1392), 256 (43%) and 511 (36.7%) participants were women, and 42 (1.7%) and 78 (1.6%) reported recent injection initiation assistance across a median of three and two follow-up visits, respectively. Women had a lower risk of providing injection initiation assistance for the first time in Tijuana (adjusted hazard ratio = 0.52, 95% confidence interval 0.27-0.99), but not in Vancouver. Gendered pathways, like sex work, were associated with providing initiation assistance for the first time in Vancouver (adjusted hazard ratio = 1.97, 95% confidence interval 1.08-3.61). DISCUSSION AND CONCLUSIONS: Women in Tijuana, but not Vancouver, were less likely to provide first-time initiation assistance among PWID. These results can inform gender- and site-specific prevention efforts aimed at reducing transitions into drug injecting across geographic contexts.
INTRODUCTION: Injection drug use initiation is commonly facilitated by other people who inject drugs (PWID). We investigated how the gender of PWID influences their risk of providing initiation assistance to others across two distinct geo-cultural settings. METHODS: Data were drawn from two prospective cohorts in Tijuana, Mexico and Vancouver, Canada which conducted semi-annual interviews within the PReventing Injecting by Modifying Existing Responses (PRIMER) study. Participants consisted of PWID who had reported never providing injection initiation assistance at baseline. We then conducted site-specific discrete-time survival analyses assessing the relationship between gender and other relevant covariates (e.g. age and past 6-month sex work) on the risk of the first reported instance of providing initiation assistance. RESULTS: Of 1988 PWID (Tijuana: n = 596; Vancouver: n = 1392), 256 (43%) and 511 (36.7%) participants were women, and 42 (1.7%) and 78 (1.6%) reported recent injection initiation assistance across a median of three and two follow-up visits, respectively. Women had a lower risk of providing injection initiation assistance for the first time in Tijuana (adjusted hazard ratio = 0.52, 95% confidence interval 0.27-0.99), but not in Vancouver. Gendered pathways, like sex work, were associated with providing initiation assistance for the first time in Vancouver (adjusted hazard ratio = 1.97, 95% confidence interval 1.08-3.61). DISCUSSION AND CONCLUSIONS: Women in Tijuana, but not Vancouver, were less likely to provide first-time initiation assistance among PWID. These results can inform gender- and site-specific prevention efforts aimed at reducing transitions into drug injecting across geographic contexts.
Authors: Vera Frajzyngier; Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Samuel R Friedman Journal: Drug Alcohol Depend Date: 2007-02-05 Impact factor: 4.492
Authors: María Luisa Mittal; Sonia Jain; Shelly Sun; Kora DeBeck; M J Milloy; Kanna Hayashi; Scott E Hadland; Dan Werb Journal: Drug Alcohol Depend Date: 2019-01-22 Impact factor: 4.492
Authors: Sanjay R Mehta; Antoine Chaillon; Tommi L Gaines; Patricia E Gonzalez-Zuniga; Jamila K Stockman; Horatio Almanza-Reyes; Jose Roman Chavez; Alicia Vera; Karla D Wagner; Thomas L Patterson; Brianna Scott; Davey M Smith; Steffanie A Strathdee Journal: Clin Infect Dis Date: 2018-02-10 Impact factor: 9.079
Authors: Kimberly C Brouwer; Patricia Case; Rebeca Ramos; Carlos Magis-Rodríguez; Jesus Bucardo; Thomas L Patterson; Steffanie A Strathdee Journal: Subst Use Misuse Date: 2006 Impact factor: 2.164
Authors: Michelle Firestone Cruz; Andrea Mantsios; Rebeca Ramos; Patricia Case; Kimberly C Brouwer; Maria Elena Ramos; Wendy Davila Fraga; Carl A Latkin; Cari L Miller; Steffanie A Strathdee Journal: AIDS Behav Date: 2007-03
Authors: Sean T Allen; Kristin E Schneider; Alyona Mazhnaya; Rebecca Hamilton White; Allison O'Rourke; Alex H Kral; Ricky N Bluthenthal; Michael E Kilkenny; Susan G Sherman Journal: AIDS Behav Date: 2021-06-02
Authors: Daniel Werb; Richard Garfein; Thomas Kerr; Peter Davidson; Perrine Roux; Marie Jauffret-Roustide; Marc Auriacombe; Will Small; Steffanie A Strathdee Journal: Harm Reduct J Date: 2016-09-15